Literature DB >> 26056859

Postoperative infections following colorectal surgery in an English teaching hospital.

Andrew Kirby1, Girvan Burnside, Laure Bretsztajn, Dermot Burke.   

Abstract

A retrospective case note review of postoperative infections within 30 days of colorectal surgery was completed. Surgical site infections (SSIs) were identified in 22% of patients (84/378), with other infections, e.g. urinary tract infections, identified in 18.3% of patients. SSIs, urinary and respiratory tract infections were all associated with increased durations of hospital admission compared with non-infected patients. Consideration should be given to postoperative surveillance for all infections, using antibiotic consumption as an objective outcome measure. Nine percent of patients developed an organ space SSI. Organ space SSIs were associated with the longest additional duration of hospital admission (15.5 days) and were the only infection associated with an increase in mortality at 1 year; 37% (13/35) mortality with an organ space SSI vs 4% (8/225) without an infection (odds ratio = 16, 95% confidence interval = 6, 43). Further research to prevent and treat organ space SSIs should be prioritized.

Entities:  

Keywords:  Co-amoxiclav; mortality; prophylaxis; surgical site infection; surveillance

Mesh:

Year:  2015        PMID: 26056859     DOI: 10.3109/23744235.2015.1055584

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  2 in total

1.  Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery.

Authors:  Andrew Kirby; Eduardo Asín-Prieto; Flora Agnes Burns; Duncan Ewin; Kavi Fatania; Mithun Kailavasan; Saira Nisar; Agamemnon Pericleous; Iñaki F Trocóniz; Dermot Burke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-12-05       Impact factor: 3.267

2.  Risk factors and outcomes of organ-space surgical site infections after elective colon and rectal surgery.

Authors:  Aina Gomila; Jordi Carratalà; Daniel Camprubí; Evelyn Shaw; Josep Mª Badia; Antoni Cruz; Francesc Aguilar; Carmen Nicolás; Anna Marrón; Laura Mora; Rafel Perez; Lydia Martin; Rosa Vázquez; Ana Felisa Lopez; Enric Limón; Francesc Gudiol; Miquel Pujol
Journal:  Antimicrob Resist Infect Control       Date:  2017-04-21       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.